Cancer Research Donn Young  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 4101, May 15, 2009. Published Online First May 12, 2009;
doi: 10.1158/0008-5472.CAN-08-2864
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-2864v1
69/10/4101    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Humbert, N.
Right arrow Articles by Bernard, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humbert, N.
Right arrow Articles by Bernard, D.

Priority Reports

A Genetic Screen Identifies Topoisomerase 1 as a Regulator of Senescence

Nicolas Humbert1, Sébastien Martien1, Arnaud Augert1, Marco Da Costa2, Sébastien Mauen3, Corinne Abbadie1, Yvan de Launoit1, Jesús Gil2 and David Bernard1

1 UMR8161, Institut de Biologie de Lille, Centre National de la Recherche Scientifique/Universités de Lille 1-2/Institut Pasteur de Lille, IFR142, Lille, France; 2 Cell Proliferation Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Campus, London, United Kingdom; and 3 Moores Cancer Center, University of California San Diego, La Jolla, California

Requests for reprints: David Bernard, Centre National de la Recherche Scientifique UMR 8161, Institut de Biologie de Lille, 1 rue du Pr Calmette BP 447, 59021 Lille Cedex, France. Phone: 33-3-20-87-11-27; Fax: 33-3-20-87-11-11; E-mail: david.bernard{at}ibl.fr.

Key Words: senescence • DNA damage • topoisomerase 1 • genetic screen

Normal cell growth can be permanently blocked when cells enter a state known as senescence. This phenomenon can be triggered by various stresses, such as replicative exhaustion, oncogenic stimulation, or oxidative stress. Senescence prevents transmission of aberrant signals to daughter cells and thus prevents irreversible damage that could favor cancer development. To identify new genetic events controlling senescence, we have performed a loss-of-function genetic screen on normal human cells. We report that knockdown of topoisomerase I (Top1) results in an increased replicative potential associated with a decrease in senescence markers and a diminished DNA damage response. In addition, Top1 depletion also favors a bypass of oncogene-induced senescence. Conversely, Top1 constitutive expression induces growth arrest, the appearance of a senescence marker, and an activation of the DNA damage response. Altogether, these results reveal an unanticipated function of Top1 in regulating senescence. [Cancer Res 2009;69(10):4101–6]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.